✦ LIBER ✦

Preclinical and clinical pharmacokinetic/pharmacodynamic considerations for antibody–drug conjugates

✍ Scribed by Sapra, Puja; Betts, Alison; Boni, Joseph

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic Considerations for Antib

✍ Kedan Lin, Jay Tibbitts 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 480 KB

Practical Considerations for the Pharmac

✍ Sauerborn, Melody; van Dongen, William 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 973 KB

Monoclonal antibodies: what are the phar

✍ Deng, Rong; Jin, Feng; Prabhu, Saileta; Iyer, Suhasini 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 514 KB

Phase I clinical studies with cytotoxic

✍ Newell, DR 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 530 KB

Monoclonal antibody drug conjugates for

✍ Johnson, I.S.; Spearman, M.E.; Todd, G.C.; Zimmerman, J.L.; Bumol, T.F. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Absorption, Distribution, Metabolism, an

✍ Han, T. H.; Zhao, B. 📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 176 KB